These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3141942)
1. Dopaminergic control of TSH secretion in endogenous depression. Marchesi C; Chiodera P; De Risio C; Dassò L; Govi AM; De Ferri A; Piagneri B; Minelli R; Bianconi L; Gnudi A Psychiatry Res; 1988 Sep; 25(3):277-82. PubMed ID: 3141942 [TBL] [Abstract][Full Text] [Related]
2. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects. Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595 [TBL] [Abstract][Full Text] [Related]
3. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. Coiro V; Butturini U; Gnudi A; Volpi R; d'Amato L; Speroni G; Capretti L; Roti E; Chiodera P Horm Res; 1987; 25(4):206-14. PubMed ID: 3108134 [TBL] [Abstract][Full Text] [Related]
4. Thyrotropin alpha- and beta-subunit responses to thyrotropin-releasing hormone and domperidone in normal subjects and in patients with microprolactinomas. Persani L; Beck-Peccoz P; Medri G; Conti A; Faglia G Neuroendocrinology; 1991 Apr; 53(4):411-5. PubMed ID: 1710792 [TBL] [Abstract][Full Text] [Related]
5. Involvement of a dopaminergic mechanism in the response of growth hormone to thyrotropin releasing hormone in patients with major depression. Marchesi C; Gnudi A; Chiodera P; De Risio C; Fava A; Dasso L; De Ferri A; Guerra M; Coiro V Pharmacopsychiatry; 1987 Mar; 20(2):64-6. PubMed ID: 3108910 [TBL] [Abstract][Full Text] [Related]
6. Effect of domperidone on prolactin (PRL)and thyrotrophin (TSH) secretion. Kaufman JM; Elewaut A; Vermeulen A Arch Int Pharmacodyn Ther; 1981 Dec; 254(2):293-303. PubMed ID: 6802092 [TBL] [Abstract][Full Text] [Related]
7. Different effects of pyridostigmine on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression and subclinical thyrotoxicosis. Coiro V; Volpi R; Marchesi C; DeFerri A; Capretti L; Caffarri G; Colla R; Chiodera P Metabolism; 1998 Jan; 47(1):50-3. PubMed ID: 9440477 [TBL] [Abstract][Full Text] [Related]
8. On the role of dopamine receptors in the central regulation of human TSH. Delitala G; Devilla L; Canessa A; D'Asta F Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078 [TBL] [Abstract][Full Text] [Related]
9. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man. Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487 [TBL] [Abstract][Full Text] [Related]
10. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea. Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222 [TBL] [Abstract][Full Text] [Related]
11. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics. Coiro V; Vescovi PP Alcohol Clin Exp Res; 1997 Oct; 21(7):1308-11. PubMed ID: 9347094 [TBL] [Abstract][Full Text] [Related]
12. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade. Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942 [TBL] [Abstract][Full Text] [Related]
13. Inappropriate thyrotrophin secretion, increased dopaminergic tone and preservation of the diurnal rhythm in serum TSH. Magee B; Sheridan B; Scanlon MF; Atkinson AB Clin Endocrinol (Oxf); 1986 Feb; 24(2):209-15. PubMed ID: 3085996 [TBL] [Abstract][Full Text] [Related]
14. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome. Valensi P; Combes ME; Perret G; Attali JR J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337 [TBL] [Abstract][Full Text] [Related]
15. Dose-response studies with thyrotropin-releasing hormone: evidence for differential pituitary responses in men with major depression, alcoholism, or no psychopathology. Garbutt JC; Mayo JP; Little KY; Gillette GM; Mason GA; Dew B; Prange AJ Alcohol Clin Exp Res; 1996 Jun; 20(4):717-22. PubMed ID: 8800390 [TBL] [Abstract][Full Text] [Related]
16. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201 [TBL] [Abstract][Full Text] [Related]
17. The TRH test during dopamine receptor blockade in depressed patients. Loosen PT; Garbutt JC; Tipermas A Psychoneuroendocrinology; 1986; 11(3):327-36. PubMed ID: 3097692 [TBL] [Abstract][Full Text] [Related]
18. Mediation by nitric oxide of TRH-, but not metoclopramide-stimulated TSH secretion in humans. Coiro V; Volpi R; Chiodera P Neuroreport; 1995 May; 6(8):1174-6. PubMed ID: 7662901 [TBL] [Abstract][Full Text] [Related]
19. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery. Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297 [TBL] [Abstract][Full Text] [Related]